Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Chikungunya, Dengue, and Zika in immunocompromised hosts (2018)

  • Authors:
  • USP affiliated authors: MACHADO, CLARISSE MARTINS - IMT
  • USP Schools: IMT
  • DOI: 10.1007/s11908-018-0612-2
  • Subjects: VÍRUS CHIKUNGUNYA; VÍRUS DA DENGUE; ZIKA VÍRUS; TRANSPLANTES; ARBOVÍRUS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11908-018-0612-2 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: bronze
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1007/s11908-018-0612-2 (Fonte: Unpaywall API)

    Título do periódico: Current Infectious Disease Reports

    ISSN: 1523-3847,1534-3146

    • Melhor URL em Acesso Aberto:


    • Outras alternativas de URLs em Acesso Aberto:
    Informações sobre o Citescore
  • Título: Current Infectious Disease Reports

    ISSN: 1523-3847

    Citescore - 2017: 1.96

    SJR - 2017: 0.825

    SNIP - 2017: 0.913


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DARRIGO JÚNIOR, Luiz Guilherme; CARVALHO, Alexandre Machado de Sant'Anna. Chikungunya, Dengue, and Zika in immunocompromised hosts. Current infectious disease reports, Philadelphia, v. 20, 2018. Disponível em: < http://dx.doi.org/10.1007/s11908-018-0612-2 > DOI: 10.1007/s11908-018-0612-2.
    • APA

      Darrigo Júnior, L. G., & Carvalho, A. M. de S. 'A. (2018). Chikungunya, Dengue, and Zika in immunocompromised hosts. Current infectious disease reports, 20. doi:10.1007/s11908-018-0612-2
    • NLM

      Darrigo Júnior LG, Carvalho AM de S'A. Chikungunya, Dengue, and Zika in immunocompromised hosts [Internet]. Current infectious disease reports. 2018 ;20Available from: http://dx.doi.org/10.1007/s11908-018-0612-2
    • Vancouver

      Darrigo Júnior LG, Carvalho AM de S'A. Chikungunya, Dengue, and Zika in immunocompromised hosts [Internet]. Current infectious disease reports. 2018 ;20Available from: http://dx.doi.org/10.1007/s11908-018-0612-2

    Referências citadas na obra
    World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control: new edition. WHO Guidel Approv by Guidel Rev Committee. 2009.
    Pandey N, Jain A, Garg RK, Kumar R, Agrawal OP, Lakshmana Rao PV. Serum levels of IL-8, IFNgamma, IL-10, and TGF beta and their gene expression levels in severe and non-severe cases of dengue virus infection. Arch Virol. 2015;160(6):1463–75.
    Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. Reithinger R, editor. PLoS Negl Trop Dis. 2012;6(8):e1760.
    Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7.
    WHO PAHO. Dengue cases in the Americas. Vol. 2017, WHO PAHO. 2017. p. 1–3. Available from: http://www.who.int/mediacentre/factsheets/2017-cha-dengue-cases-mar-27-ew-11.pdf?ua=1 .
    •• de Souza Pereira BB, Darrigo Junior LG, de Mello Costa TC, Felix AC, Simoes BP, Stracieri AB, et al. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Transpl Infect Dis. 2017;19(4):e12721. Article showing prolonged viremia in dengue cases with blood samples taken prospectively, and awares the consequences on graft function.
    Weerakkody R, Palangasinghe D, Dalpatadu KP, Rankothkumbura J, Cassim MR, Karunanayake P. Dengue fever in a liver-transplanted patient: a case report. J Med Case Rep. 2014;8(1):378.
    Fernandes PFCBC, Siqueira RA, Girão ES, Siqueira RA, Mota MU, Marques LCBF, et al. Dengue in renal transplant recipients: clinical course and impact on renal function. World J Transplant. 2017;7(1):57–63.
    •• Nasim A, Anis S, Baqi S, Akhtar SF, Baig-Ansari N. Clinical presentation and outcome of dengue viral infection in live-related renal transplant recipients in Karachi, Pakistan. Transpl Infect Dis. 2013;15(5):516–25. Largest series of DENV in renal transplant recipients, showing transient graft disfunction and liver enzymes alterations.
    Machado CM. Transplant infections in developing countries. In: Ljungman P, Snydman D, Boeckh M, editors. Transplant infections. 4th ed. 2016. p. 129–50.
    Weerakkody RM, Patrick JA, Sheriff MHR. Dengue fever in renal transplant patients: a systematic review of literature. BMC Nephrol. 2017;18(1):15.
    • Rigau-Pérez JG, Vorndam AV, Clark GG. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg. 2001;64(1–2):67–74. First case of Dengue transmission by the graft in HSCT recipient.
    Punzel M, Korukluoğlu G, Caglayik DY, Menemenlioglu D, Bozdag SC, Tekgündüz E, et al. Dengue virus transmission by blood stem cell donor after travel to Sri Lanka; Germany, 2013. Emerg Infect Dis. 2014;20(8):1366–9.
    Tan FL-S, Loh DLSK, Prabhakaran K. Dengue haemorrhagic fever after living donor renal transplantation. Nephrol Dial Transplant. 2005;20:447–8.
    • Gupta RK, Gupta G, Chorasiya VK, Bag P, Shandil R, Bhatia V, et al. Dengue virus transmission from living donor to recipient in liver transplantation: a case report. J Clin Exp Hepatol. 2016;6(1):59–61. First case of Dengue transmission by the graft in SOT recipient.
    •• Busch MP, Linnen JM, Vinelli E, Sabino EC, Tobler LH, Hyland C, et al. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion. 2008;48(7):1355–62. First evidence of possible blood transmission of dengue.
    Dias LL, Amarilla AA, Poloni TR, Covas DT, Aquino VH, Figueiredo LTM. Detection of dengue virus in sera of Brazilian blood donors. Transfusion. 2012;52(8):1667–71.
    Levi JE, Nishiya A, Félix AC, Salles NA, Sampaio LR, Hangai F, et al. Real-time symptomatic case of transfusion-transmitted dengue. Transfusion. 2015;55(5):961–4.
    Sabino EC, Loureiro P, Esther Lopes M, Capuani L, McClure C, Chowdhury D, et al. Transfusion-transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis. 2016;212(11):694–702.
    • Alfaro A, Guzman MG, Martinez E, Pizarro D, Pleites E, Gutierrez FH, et al. Dengue: guidelines for patient care in the region of the Americas. 2nd ed. Pan American Health Organization (PAHO), World Health Organization (WHO), editors. Washington, DC; 2016. 136 p. New clinical classification of Dengue.
    Petersen LR, Tomashek KM, Biggerstaff BJ. Estimated prevalence of dengue viremia in Puerto Rican blood donations, 1995 through 2010. Transfusion. 2012;52(8):1647–51.
    Guilardea O, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, Levi JE, et al. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis. 2008;197(6):817–24.
    • Qing M, Yang F, Zhang B, Zou G, Robida JM, Yuan Z, et al. Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob Agents Chemother. 2009;53(8):3226–35. Possible therapeutic effect of cyclosporine on DENV.
    Cox J, Mota J, Sukupolvi-Petty S, Diamond MS, Rico-Hesse R. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol. 2012;86(14):7637–49.
    Keasey SL, Pugh CL, Jensen SMR, Smith JL, Hontz RD, Durbin AP, et al. Antibody responses to Zika virus infections in environments of Flavivirus endemicity. Clin Vaccine Immunol. 2017;24(4):1–16.
    •• Felix AC, Souza NCS, Figueiredo WM, Costa AA, Inenami M, da Silva RMG, et al. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol. 2017;89(8):1477–9. This article shows the cross-reactivity of commercial kits of dengue serology in serum from patients with acute ZIKV infection.
    •• Machado CM, Pereira BBS, Felix AC, Oliveira MC, Darrigo LG, de Souza MP, et al. Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients. Blood Adv. 2017;1(10):624–7. First prospective study of arbovirus in hematopoietic stem cell transplant recipients and oncohematological patients. Highlights the protracted and more severe course of Dengue and prolonged viremia.
    Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955;49(1):28–32.
    Morens DM, Fauci AS. Chikungunya at the Door-Déjà Vu All Over Again? N Engl J Med. 2014;371(10):885–7.
    Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015;372(13):1231–9.
    Mathew AJ, Ganapati A, Kabeerdoss J, Nair A, Gupta N, Chebbi P, et al. Chikungunya infection: a global public health menace. Curr Allergy Asthma Rep. 2017;17(2):1–9.
    Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007;88(Pt 9):2363–77.
    da Cunha RV, Trinta KS. Chikungunya virus: clinical aspects and treatment—a review. Mem Inst Oswaldo Cruz. 2017;112(8):523–31.
    Nhan TX, Claverie A, Roche C, Teissier A, Colleuil M, Baudet JM, et al. Chikungunya virus imported into French Polynesia, 2014. Emerg Infect Dis. 2014;20(10):1773–4.
    Faria NR, Lourenço J, Marques de Cerqueira E, Maia de Lima M, Carlos Junior Alcantara L. Epidemiology of chikungunya virus in Bahia, Brazil, 2014–2015. PLOS Currents Outbreaks. 2016 Feb 1. Edition 1.
    Collucci C. Brazil sees sharp rise in chikungunya cases. BMJ. 2016;354(i4560):4560.
    • Couderc T, Gangneux N, Chrétien F, Caro V, Le Luong T, Ducloux B, et al. Chikungunya virus infection of corneal grafts. J Infect Dis. 2012;206(6):851–9. First publication of possible transmission of CHIKV by corneal grafts during epidemics.
    Appassakij H, Promwong C, Rujirojindakul P, Wutthanarungsan R, Silpapojakul K. The risk of blood transfusion-associated chikungunya fever during the 2009 epidemic in Songkhla Province. Thail Transfus. 2014;54(8):1945–52.
    •• Abdelnabi R, Neyts J, Delang L. Chikungunya virus infections: time to act, time to treat. Curr Opin Virol. 2017;24:25–30. This study documented some of the recently small molecule inhibitors of CHIKV replication.
    Mccarthy MK, Morrison TE. Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms ? Future Microbiol. 2016;11:331–4.
    Lemant J, Boisson V, Winer A, Thibault L, André H, Tixier F, et al. Serious acute chikungunya virus infection requiring intensive care during the reunion island outbreak in 2005–2006. Crit Care Med. 2008;36(9):2536–41.
    Kee ACL, Yang S, Tambyah P. Atypical chikungunya virus infections in immunocompromised patients. Emerg Infect Dis. 2010;16:1038–40.
    Dalla Gasperina D, Balsamo ML, Garavaglia SD, Rovida F, Baldanti F, Grossi PA. Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic. Transpl Infect Dis. 2015;17(6):876–9.
    Pierrotti LC, Lopes MIBF, do NAP, Caiaffa-Filho H, Lemos FBC, Reusing JO, et al. Chikungunya in kidney transplant recipients: a series of cases. Int J Infect Dis. 2017;64:96–9.
    •• Girão ES, Rodrigues BG, Santos D, Do Amaral ES, Costa PEG, Pereira KB, et al. Chikungunya infection in solid organ transplant recipients. Transplant Proc. 2017;49(9):2076–81. This study described the largest number of CHIKV infection in solid organ transplant recipients and their particularities.
    •• Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet. 2012;379(9816):662–71. This article provides a current overview of Chikungunya with special attention to the clinical manifestations and pathogenesis.
    Wang YM, Lu JW, Lin CC, Chin YF, Wu TY, Lin LI, et al. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission. Antivir Res. 2016;135:81–90.
    •• Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika Virus. N Engl J Med. 2016;374(16):1552–63. This article provides a current overview of Zika Virus.
    Mac Namara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg. 1954;48(2):139–45.
    Duffy MR, Chen T-H, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360(24):2536–43.
    Ioos S, Mallet HP, Leparc Goffart I, Gauthier V, Cardoso T, Herida M. Current Zika virus epidemiology and recent epidemics. Med Mal Infect. 2014;44(7):302–7.
    Who. Zika Americas. Wkly Epidemiol Rec. 2015;(45):609–16.
    Shirley D-AT, Nataro JP. Zika virus infection. Pediatr Clin N Am. 2017;64(4):937–51.
    Jimenez A, Shaz BH, Kessler D, Bloch EM. How do we manage blood donors and recipients after a positive Zika screening result? Transfusion. 2017;57(9):2077–83.
    Ikejezie J, Shapiro CN, Kim JChiu M, Almiron M, Ugarte C, Espinal MA, et al. Zika virus transmission—region of the Americas, May 15, 2015–December 15, 2016. Am J Transplant. 2017;17:1681–6.
    Faria NR, Azevedo R, Kraemer MUG, Souza R, Cunha MS, Hill SC, et al. Zika virus in the Americas: early epidemiological and genetic findings. Science. 2016;352(6283):345–9.
    Salvador FS, Fujita DM. Entry routes for Zika virus in Brazil after 2014 world cup: new possibilities. Travel Med Infect Dis. 2015;2015:1–3.
    Basile K, Kok J, Dwyer DE. Zika virus: what, where from and where to? Pathology. 2017;49(7):698–706.
    •• Nogueira ML, Estofolete CF, Terzian ACB, Mascarin do Vale EPB, da Silva RCMA, da Silva RF, et al. Zika virus infection and solid organ transplantation: a new challenge. Am J Transplant. 2017;17(3):791–5. Largest Zika case series in solid organ transplantation.
    • Schwartzmann PV, Ramalho LNZ, Neder L, Vilar FC, Ayub-Ferreira SM, Romeiro MF, et al. Zika virus meningoencephalitis in an immunocompromised patient. Mayo Clin Proc. 2017;92(3):460–6. This article showed that reducing IS because of zika infection led to graft rejection and death.
    Simkins J, Anjan S, Morillas-Rodriguez JA, Greissman SR, Abbo LM, Camargo JF, Ruiz P, Vianna R, Guerra G, Salama S, Morris MI Screening for Zika virus in deceased organ donors in Florida. Am J Transplant. 2017.
    •• Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Eurosurveillance. 2014;19(14). First paper to highlight the potential risk of transfusion transmission of ZIKV.
    Kuehnert MJ, Basavaraju SV, Moseley RR, Pate LL, Galel SA, Williamson PC, et al. Screening of blood donations for Zika virus infection - Puerto Rico, April 3-June 11, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(24):627–8.
    Slavov SN, Hespanhol MR, Rodrigues ES, Levi JE, Ubiali EMA, Covas DT, et al. Zika virus RNA detection in asymptomatic blood donors during an outbreak in the northeast region of São Paulo state, Brazil, 2016. Transfusion. 2017;57(12):2897–901.
    • Barjas-Castro ML, Angerami RN, Cunha MS, Suzuki A, Nogueira JS, Rocco IM, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion. 2016;56(7):1684–8. First report of ZIKV in liver transplant recipient, transmitted by platelet component.
    Motta IJF, Spencer BR, Cordeiro da Silva SG, Arruda MB, Dobbin JA, Gonzaga YBM, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med. 2016;375(11):1101–3.
    US Department of Health and Human Services. Guidance on zika virus. Organ procurement and transplantation Network July 28, 2016. Available from: https://optn.transplant.hrsa.gov/news/guidance-on-zika-virus/ .
    •• Kleber de Oliveira W, Cortez-Escalante J, De Oliveira WTGH, do Carmo, GMI, Henriques CMP, Coelho GE, et al. Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed zika virus transmission during the first trimester of Pregnancy-Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(9). First report of increase of microcephaly cases after ZIKV infection in pregnant women.
    de Paula Freitas B, de Oliveira Dias JR, Prazeres J, Sacramento GA, Ko AI, Maia M, et al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol. 2016;134(5):529.
    Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects-reviewing the evidence for causality. N Engl J Med. 2016;374(20):1981–7.
    Raboni SM, Bonfim C, Almeida BM, Zanluca C, Koishi AC, Rodrigues PRVP, et al. Flavivirus cross-reactivity in serological tests and Guillain-Barré syndrome in a hematopoietic stem cell transplant patient: a case report. Transpl Infect Dis. 2017;19(4):1–5.
    Thiery G, Valentino R, Meddhaoui H. Zika virus-associated Guillain–Barré syndrome: a warning for critical care physicians. Intensive Care Med. 2016;42(9):1485–6.
    Siu R, Bukhari W, Todd A, Gunn W, Huang QS, Timmings P. Acute Zika infection with concurrent onset of Guillain-Barré syndrome. Neurology. 2016;87:1623–4.
    Styczynski J, Hoek J, Knelange N, Mikulska M, Cesaro S, Aljurf M, et al. No report on Zika virus infection in EBMT registry: infectious diseases working party statement. Bone Marrow Transplant. 2017;52(9):1345–6.
    Silveira FP, Campos SV. The Zika epidemics and transplantation. J Hear Lung Transplant. 2016;35(5):560–3.
    Shukla S, Hong S-Y, Chung SH, Kim M. Rapid detection strategies for the global threat of Zika virus: current state, new hypotheses, and limitations. Front Microbiol. 2016;7:1685.
    • Mansuy JM, Mengelle C, Pasquier C, Chapuy-regaud S, Delobel P, Martin-blondel G. Zika virus infection and prolonged viremia in whole-blood specimens. Emerg Infect Dis. 2017;23(5):2015–7. The article shows prolonged detection of ZIKV in whole blood and highlights the impact of this finding in donor deferral by blood banks.
    Gourinat AC, OConnor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of zika virus in urine. Emerg Infect Dis. 2015;21(1):84–6.
    Musso D, Roche C, Nhan T-X, Robin E, Teissier A, Cao-Lormeau V-M. Detection of Zika virus in saliva. J Clin Virol. 2015;68(1):53–5.
    Heald-Sargent T, Muller W. Zika virus: a review for pediatricians. Pediatr Ann. 2017;46(11):e428–32.
    Wichmann O, Vannice K, Asturias EJ, de Albuquerque Luna EJ, Longini I, Lopez AL, et al. Live-attenuated tetravalent dengue vaccines: the needs and challenges of post-licensure evaluation of vaccine safety and effectiveness. Vaccine. 2017;35(42):5535–42.
    Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373(13):1195–206.
    •• World Health Organization. Dengue vaccine: WHO position paper – July 2016. Vol. 30, Weekly Epidemiological Report. 2016. Available from: http://www.who.int/wer/2016/wer9130.pdf?ua=1 . WHO opinion on the limitations of the licensed dengue vaccine and its risks if used in low seroprevalence areas.
    Magnani DM, Silveira CGT, Ricciardi MJ, Gonzalez-Nieto L, Pedreño-Lopez N, Bailey VK, et al. Potent plasmablast-derived antibodies elicited by the National Institutes of Health Dengue Vaccine. J Virol. 2017;91(22):e00867–17.
    Barzon L, Palù G. Current views on Zika virus vaccine development. Expert Opin Biol Ther. 2017;17(10):1185–92.
    U.S. Department of Health and Human Services. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components. Guidance for industry [Internet]. FDA. 2016. Available from: http://www.fda.gov/BiologicsBloodVaccines/Guidance .
    UNOS. Guidance for organ donation and transplantation professionals regarding the Zika virus [Internet]. 2016. Available from: https://unos.org/guidance-for-organ-donation-and-transplantation-professionals-regarding-the-zika-virus/ .